Sensipar (Cinacalcet)

Sensipar/Mimpara (cinacalcet) is a positive modulator of the calcium-sensing receptor indicated for:

• Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.
• Hypercalcemia in adult patients with Parathyroid Carcinoma (PC)
• Hypercalcemia in adult patients with primary HPT for whom parathyroidectomy would be indicated based on serum calcium levels, but who are unable to undergo parathyroidectomy.

Limitations of Use: This therapeutic drug is not indicated for use in patients with CKD who are not on dialysis.

Recommended Dosage: The recommended dosage of Cinacalcet needs to be taken with food or right after a meal. Prescribed oral tablets should be taken whole, with water, and not chewed, crushed, or broken out in pieces.

Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease on Dialysis: The recommended starting oral dose of Cinacalcet is 30 mg once daily. Within a week, checking serum calcium and serum phosphorus levels is necessary and, within 1 iPTH hormones can be measured 1 to 4 weeks after the initiation or the dose adjustment of Cinacalcet. Titration is to be done no more frequently than every 2-4 weeks, with 30 mg, 60 mg, 90 mg, 120 mg, and 180 mg daily doses till the targeted iPTH range level is 150-300 pg/mL. Level measurement of serum iPTH should be taken no less than 12 hours after dosing with Cinacalcet.

Patients with Parathyroid Carcinoma and Primary Hyperparathyroidism: The recommended starting oral dose of Cinacalcet is 30 mg twice daily. The dose of Cinacalcet should be titrated every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg 3 or 4 times daily as necessary to normalize serum calcium levels. Serum calcium should be measured within 1 week after initiation or dose adjustment of Cinacalcet.

• Cinacalcet's effects can result in tremors and tingling or more severe symptoms such as seizures, imbalanced heartbeats, and even profound muscle cramps due to hypocalcemia. To avert those complications, calcium concentrations must be kept in check since they may warrant load-level adjustments.
• Nausea, vomiting, and abdominal discomfort are some of the symptoms people experience post-treatment with Cinacalcet that may result in upper gastrointestinal hemorrhage. Bleeding prudence should be exercised in patients with a previous history of ulcers or any other digestive ailment.
• The chronic application of Cinacalcet causes a decline in bone replacement rate, thereby resulting in increased bone fragility and higher chances of osteoporosis. Any such threats require closer monitoring to ensure bone health in patients suffering from persistent kidney issues or parathyroid problems.
• Side effects of Cinacalcet can be lower than normal blood pressure which increases chances of weakness and fainting spells along with persistent dizziness. However, such symptoms should not be frequent. Care should be taken around patients who already have low blood pressure, especially those who use blood pressure-lowering medications.
• Patients suffering from heart ailments are likely to have inefficient heart performance or arrhythmic beating. What is concerning is that changes in calcium levels are happening. It must be of utmost importance to limit these side effects by consistently changing treatment to mitigate the effects on heart diseases.
• Cinacalcet 30 mg, 60 mg, and 90 mg should be prescribed during pregnancy only in rare cases. The existing human information is quite scant, and animal studies show risks to the fetus. Therefore, pregnant women consulting their physician beforehand is crucial so that all benefits and risks can be analyzed before using this drug.
• Cinacalcet oral tablets can be excreted into breast milk and affect the infant. There are very few safety studies, so breastfeeding mothers should either avoid this drug or stop breastfeeding. Please speak with your doctor on how to address calcium disorders while nursing.

What documents are required to import SENSIPAR/MIMPARA to India?

SENSIPAR/MIMPARA (cinacalcet) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
A valid prescription from a qualified doctor.
Patients diagnostic reports
Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is SENSIPAR/MIMPARA available in India?

SENSIPAR/MIMPARA (cinacalcet tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Sensipar/Mimpara in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

SENSIPAR/MIMPARA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of SENSIPAR/MIMPARA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Sensipar/Mimpara price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source SENSIPAR/MIMPARA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Sensipar®?

Cinacalcet is a Generic Name for the trade name drug Sensipar®.

What is the Manufacturer's Name of Sensipar/Mimpara®?

Sensipar® is manufactured by Amgen Inc.

Is Sensipar approved by the FDA?

Yes, Sensipar® is approved by the FDA. Date of first approval: March 8, 2004.

What is the dosage and form of Sensipar® supplied?

Sensipar is supplied in Tablets: 30, 60, and 90 mg tablets for oral administration.

What are the most common side effects of Sensipar® 30 mg/60 mg/90 mg Tablets?

The most common side effects of Sensipar® 30, 60, and 90 mg tablets are nausea and vomiting.

How much does Sensipar® 30 mg/60 mg/90 mg Tablets cost in India?

Prices of Sensipar 30 mg/60 mg/90 mg tablets may fluctuate over time because of market dynamics and regulatory changes. To get the most transparent Sensipar 30 mg/60 mg/90 mg cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Sensipar® 30 mg/60 mg/90 mg Tablets be available in SAARC countries?

Apart from Gulf countries, Sensipar/Mimpara® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Sensipar/Mimpara® Tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Sensipar® 30 mg/60 mg/90 mg Tablets online in India?

Yes, one can buy Sensipar 30 mg/60 mg/90 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Sensipar/Mimpara® oral tablets through legal channels.

What are the storage conditions of Sensipar® 30 mg/60 mg/90 mg Tablets?

Store these oral tablets at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F).